Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Open Access Dissertations and Theses Community
  3. Open Access Dissertations and Theses
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/32264
Title: SARS-CoV-2 Vaccination Responses in Vulnerable Populations
Authors: Benoit, Jenna
Advisor: Bowdish, Dawn
Department: Medical Sciences (Molecular Virology and Immunology Program)
Publication Date: 2025
Abstract: Immunosuppressive medications are commonly prescribed to minimize the aberrant inflammatory responses in the autoimmune disorders rheumatoid arthritis (RA) and systemic sclerosis (SSc). It has been previously shown that immunosuppressive drugs can negatively impact responses to vaccination, though the impact differs by vaccine type. With the advent of the SARS-CoV-2 pandemic, and the development of new mRNA vaccines, it was unclear how well participants with RA and SSc, on immunosuppressive drugs, would response to these vaccinations. We hypothesized that people with RA or SSc, on immunomodulatory drugs, would have weaker humoral and cellular responses to SARS-CoV-2 vaccination, even following subsequent vaccinations, compared with healthy controls. To explore this, we collected blood and serum from participants with RA, SSc, and controls at various timepoints after multiple SARS-CoV-2 vaccinations. In Chapter 2, we determined that participants with RA on immunosuppressive drugs had weaker humoral and spike-specific CD4+ T cell responses, but not weaker spike-specific CD8+ T cell responses, than controls around the second, third, and fourth SARS-CoV-2 vaccinations. While costimulation inhibitors negatively impacted the humoral responses, the inclusion of JAK inhibitors in the immunosuppressive drug regimen was associated with weaker spike-specific CD4+ T cell responses, demonstrating that different immunosuppressive drugs impact unique arms of the memory response. In Chapter 3, we discovered that participants with SSc did not have lower humoral or spike-specific T cell responses to SARS-CoV-2 vaccination than controls. In Chapter 5, we determined that repeated SARS-CoV-2 vaccination did not cause T cell exhaustion in multiple vulnerable populations, including immunosuppressed participants with RA and older adults in long-term care, or healthy younger adults. Overall, our research has provided insight into SARS-CoV-2 vaccination responses in participants with RA and SSc, allowing patients and their doctors to make informed decisions regarding vaccination timelines and medication-specific concerns.
URI: http://hdl.handle.net/11375/32264
Appears in Collections:Open Access Dissertations and Theses

Files in This Item:
File Description SizeFormat 
Benoit_Jenna_M_finalsubmission2025August_PhD.pdf
Open Access
11.4 MBAdobe PDFView/Open
Show full item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue